
Kid on cutting edge in diabetes trial
Jackson 6-year-old tests new insulin pump for Type 1 youngsters.
Cashs mom, Mills Halpin, encourages him to eat more chicken at dinner with his brother in late June. Getting the right amount of carbs can be a guessing game because sometimes he doesnt eat everything, she said.
Cash Halpin shovels the last bite of rice into his mouth and asks for another serving.
I ate all the carbs, he proudly announces, mouth still full.
Yeah, says his mother, Mills Halpin, who rolls her eyes at her 6-year-old son. Eat some protein.
His father, Mike Halpin, is beside him on an opened laptop, checking the latest data available from Cashs insulin pump. The boy is part of a clinical trial testing the Medtronic MiniMed670G, a system capable of continuously monitoring his glucose levels and making microadjustments to keep them consistent throughout the day.
Cash is in the youngest group of participants to be tested, ages 2 to 6. The same Medtronic model was approved by the U.S. Food and Drug Administration last fall for ages 14 and up.
Mike Halpin administers about a unit of insulin, a tiny bubble of hormone to handle the approximately 35 grams of carbs Cash is consuming for dinner. Manual adjustments are still required at mealtimes, but the new system offers his parents a little reprieve, something they havent experienced since hewas diagnosed three years ago.
Halpin has to wear an insulin pump at all times, which monitors his levels and injects insulin when needed through an infusion port under his skin.
With this new system, if they are off a little you just cant be exact all the
Continue
reading